Omeros (OMER) Short term Debt (2011 - 2025)

Omeros' (OMER) quarterly Short term Debt came in at $17.1 million in Q4 2025, down 18.75% year-on-year from $21.0 million in Q4 2024, and down 36.64% quarter-over-quarter from $26.9 million in Q1 2025.

Omeros (OMER) Short term Debt (2011 - 2025) Analysis & Trends

Omeros has disclosed Short term Debt across 12 years of filings, most recently posting $17.1 million for Q4 2025.

  • Short term Debt for Q4 2025 came in at $17.1 million, down 18.75% year-over-year; the trailing twelve-month figure through Dec 2025 was $17.1 million (down 18.75% YoY), and the FY2025 annual result was $17.1 million, down 18.75% from the prior year.
  • Short term Debt came in at $17.1 million for Q4 2025 at Omeros, down from $26.9 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $94.9 million in Q3 2023 to a low of $17.1 million in Q4 2025.
  • The 4-year median for Short term Debt is $94.4 million (2022), against an average of $63.4 million.
  • Peak annual rise in Short term Debt reached 18.75% in 2025, while the deepest fall reached 18.75% in 2025.
  • Omeros' Short term Debt stood at $94.4 million in 2022, then increased by 0.56% to $94.9 million in 2023, then slumped by 77.87% to $21.0 million in 2024, then retreated by 18.75% to $17.1 million in 2025.
  • The last three Short term Debt figures came in at $17.1 million (Q4 2025), $26.9 million (Q1 2025), and $21.0 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Omeros 737.87 Mn 602.55 Mn 9.31 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 17.06 Mn
Mar 31, 2025 26.93 Mn
Dec 31, 2024 21.00 Mn
Sep 30, 2023 94.91 Mn
Jun 30, 2023 94.73 Mn
Mar 31, 2023 94.55 Mn
Dec 31, 2022 94.38 Mn
Mar 31, 2019 2.56 Mn
Dec 31, 2018 889,000.00
Sep 30, 2018 560,000.00
Jun 30, 2018 608,000.00
Mar 31, 2018 513,000.00
Dec 31, 2017 490,000.00
Sep 30, 2017 368,000.00
Jun 30, 2017 250,000.00
Mar 31, 2017 228,000.00
Dec 31, 2016 198,000.00
Sep 30, 2016 190,000.00
Jun 30, 2016 193,000.00
Mar 31, 2016 69,000.00